Biocon Biologics launches YESINTEK, a Stelara biosimilar, in the United States EP News Bureau Feb 25, 2025 Biocon Biologics enters US market with YESINTEK, offering treatment options for Crohn’s disease, ulcerative colitis, plaque…
Lupin launches Bumetanide injection USP in the United States EP News Bureau Nov 21, 2024 Generic equivalent of Bumex approved for treating edema in multiple conditions
US secures 300 million doses of potential AstraZeneca COVID-19 vaccine Reuters May 22, 2020 While not yet proven to be effective against the coronavirus, vaccines are seen by world leaders as the only real way to restart…
